Santos ES,
Rodrigues-Fernandes CI, Cabral JC, Fonseca FP, Leme AFP. Epigenetic alterations
in ameloblastomas: A literature review. J Clin Exp Dent. 2021;13(3):e295-302.
doi:10.4317/jced.56191
https://doi.org/10.4317/jced.56191
___________
References
|
1.
Garzon R, Calin GA, Croce CM. MicroRNASs in cancer. Ann Ver Med.
2009;60:167-179. |
|
|
|
|
|
2.
You JS, Jones PA. Cancer genetics and epigenetics: Two sides of the same
coin? Cancer Cell. 2012;22:9-20. |
|
|
|
|
|
3.
Farias LC, Gomes CC, Rodrigues MC, Gomez RS. Epigenetic regulation of matrix
metalloproteinase expression in ameloblastoma. BMC Clin Pathol. 2012;12:11. |
|
|
|
|
|
4.
Guimarães DM, Antunes DM, Duarte CME, Nunes FD. DNA methyltransferase
immunohistochemical expression in odontogenic tumors. J Oral Pathol Med.
2015;44:59-66. |
|
|
|
|
|
5.
Biswas S, Rao CM. Epigenetics in cancer: Fundamentals and beyond. Pharmacol
Ther. 2017;173:118-134. |
|
|
|
|
|
6.
Costa FF. Epigenomics in cancer management. Cancer Manag Res. 2010;2:255-265. |
|
|
|
|
|
7.
Sandoval-Basilio J, Gonzaléz-Gonzaléz R, Bologna-Molina R, Isiordia-Espinoza
M, Leija-Montoya G, Alcaraz-Estrada SL, et al. Epigenetic mechanisms in
odontogenic tumors: A literature review. Arch Oral Biol. 2018;87:211-217. |
|
|
|
|
|
8.
Barau J, Teissandier A, Zamudio N, Roy S, Nalesso V, Héraul Y, et al. The DNA
methyltransferase DNMT3C protects male germ cells from transposon activity.
Science. 2016;354:909-912. |
|
|
|
|
|
9.
Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and
beyond. Nat Rev Genet. 2012;13:484-92. |
|
|
|
|
|
10.
Jerónimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ, et al.
Epigenetics in prostate cancer: biologic and clinical relevance. Eur Urol.
2011;60:753-766. |
|
|
|
|
|
11.
Guil S, Esteller M. DNA methylomes, histone codes and miRNAs: tying it all
together. Int J Biochem Cell Biol. 2009;41:87-95. |
|
|
|
|
|
12.
Diniz MG, França JA, Vilas-Boas FA, de Souza FT, Calin GA, Gomez RS, et al.
The long noncoding RNA KIAA0125 is upregulated in ameloblastomas. Pathol Res
Pract. 2019;215:466-469. |
|
|
|
|
|
13.
Kouzarides T. Chromatin modifications and their function. Cell.
2007;128:693-705. |
|
|
|
|
|
14.
Costa SFS, Pereira NB, Pereira KMA, Campos K, de Castro WH, Diniz MG, et al.
DNA methylation pattern of apoptosis-related genes in ameloblastoma. Oral
Dis. 2017;23:779-783. |
|
|
|
|
|
15.
El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors:
Odontogenic and maxillofacial bone tumours. In: WHO classification of head
and neck tumours. Lyon, France: IARC; 2017 |
|
|
|
|
|
16.
Philipsen HP1, Reichart PA. Classification of odontogenic tumours. A
historical review. J Oral Pathol Med. 2006;35:525-9. |
|
|
|
|
|
17.
Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, et al.
Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res.
2014;20:5517-26. |
|
|
|
|
|
18.
Nikolic N, Carkic J, Ilic Dimitrijevic I, Eljabo N, Radunovic M, Anicic B, et
al. P14 methylation: an epigenetic signature of salivary gland mucoepidermoid
carcinoma in the Serbian population. Oral Surg Oral Med Oral Pathol Oral
Radiol. 2018;125:52-58. |
|
|
|
|
|
19.
Gil J, Bernard D, Peters G. Role of polycomb group proteins in stem cell
self-renewal and cancer. DNA Cell Biol. 2005;24:117-125. |
|
|
|
|
|
20.
Setién-Olarra A, Marichalar-Mendia X, Bediaga NG, Aguirre-Echebarria P,
Aguirre-Urizar JM, Mosqueda-Taylor A. MicroRNAs expression profile in solid
and unicystic ameloblastomas. PloS One. 2017;12:e0186841. |
|
|
|
|
|
21.
Duan L, Wu Y, Liang Y, Wan D, Zhang D, Zhang B. MiRNA-516b inhibits
ameloblastoma cell proliferation and invasion by regulating
MYCBP/c-myc/RECK/MMP pathway. Transl Cancer Res. 2017;6:667-678. |
|
|
|
|
|
22.
Lapthanasupkul P, Juengsomjit R, Poomsawat S, Arayapisit T. Expression
profile of polycomb group proteins in odontogenic keratocyst and
ameloblastoma. Acta Histochem. 2018;120:215-220. |
|
|
|
|
|
23.
Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps.
Nat Rev Genet. 2007;8:286-98. |
|
|
|
|
|
24.
Costa FF, Paixão VA, Cavalher FP, Ribeiro KB, Cunha IW, Rinck JA Jr, et al.
SATR-1 hypomethylation is a common and early event in breast cancer. Cancer
Genet Cytogenet. 2006;165:135-143. |
|
|
|
|
|
25.
Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO. Regulation of
matrix metalloproteinase activity in health and disease. FEBS J.
2001;278:28-45. |
|
|
|
|
|
26.
Qian Y, Huang HZ. The role of RANKL and MMP-9 in the bone resorption caused
by ameloblastoma. J Oral Pathol Med. 2010;39:592-598. |
|
|
|
|
|
27.
Abiko Y, Nagayasu H, Takeshima M, Yamazak, M, Nishimura M, Kusano K, et al.
Ameloblastic carcinoma ex ameloblastoma: report of a case-possible
involvement of CpG island hypermethylation of the p16 gene in malignant
transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2007;103:72-76. |
|
|
|
|
|
28.
Moreira PR, Guimarães MM, Gomes CC, Diniz MG, Brito JA, de Castro WH, et al.
Methylation frequencies of cell-cycle associated genes in epithelial
odontogenic tumours. Arch Oral Biol. 2009;54:893-7. |
|
|
|
|
|
29.
Schumann GG, Gogvadze EV, Osanai-Futahashi M, Kuroki A, Münk C, Fujiwara H,
et al. Unique functions of repetitive transcriptomes. Int Rev Cell Mol Biol.
2012;285:115-88. |
|
|
|
|
|
30.
Kitkumthorn N, Mutirangura A. LINE-1 methylation difference between
ameloblastoma and keratocystic odontogenic tumor. Oral Dis. 2010;16:286-91. |
|
|
|
|
|
31.
Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, Jiang J, et al. Gene
expression profiles and molecular markers to predict recurrence of Dukes' B
colon cancer. J Clin Oncol. 2004;22:1564-1571. |
|
|
|
|
|
32.
Yao K, Wang Q, Jia J, Zhao H. A competing endogenous RNA network identifies
novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic
cancer. Tumor Biol. 2017;39:1010-4283 |
|
|
|
|
|
33.
Gomes CC, de Sousa SF, Calin GA, Gomez RS. The emerging role of long
noncoding RNAs in oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol.
2017;123:235-241. |
|
|
|
|
|
34.
Wang F, Li Y, Wu X, Yang M, Cong W, Fan Z, et al. Transcriptome analysis of
coding and long non-coding RNAs highlights the regulatory network of cascade
initiation of permanent molars in miniature pigs. BMC Genomics. 2017;18:148. |
|
|
|
|
|
35.
Taira T, Maëda J, Onishi T, Kitaura H, Yoshida S, Kato H, et al. AMY-1, a
novel C-MYC binding protein that stimulates transcription activity of C-MYC.
Genes Cells. 1998; 3:549-565. |
|
|
|
|
|
36.
Davanian H, Balasiddaiah A, Heymann R, Sundström M, Redenström P,
Silfverberg, M, et al. Ameloblastoma RNA profiling uncovers a distinct
non-coding RNA signature. Oncotarget. 2017;8:4530-4542. |
|
|
|
|
|
37.
Gao L, Ma J, Mannoor K, Guarnera MA, Shetty A, Zhan M, et al. Genome-wide
small nucleolar RNA expression analysis of lung cancer by next-generation
deep sequencing. Int J Cancer. 2015;136:E623-629. |
|
|
|
|
|
38.
Choi CH, Choi JJ, Park YA, Lee YY, Song SY, Sung CO, et al. Identification of
differentially expressed genes according to chemosensitivity in advanced
ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival.
Br J Cancer. 2012; 107:91-99. |
|
|
|
|
|
39.
Webber LP, Wagner VP, Curra M, Vargas PA, Meurer L, Carrard VC, et al.
Hypoacetylation of acetyl-histone H3 (H3K9ac) as marker of poor prognosis in
oral cancer. Histopathology. 2017;71:278-286. |
|
|
|
|
|
40.
Zheng LW, Zhang BP, Xu RS, Xu X, Ye L, Zhou XD. Bivalent histone
modifications during tooth development. Int J Oral Sci. 2014;6:205-11. |
|